Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
RFID Blood Monitoring Systems Market: By Products, By End Use By Region Forecast 2019-2030
RFID Blood Monitoring Systems Market: By Products, By End Use By Region Forecast 2019-2030
RFID Blood Monitoring Systems Market size was valued at US$ 114.2 million in 2023, growing at a CAGR of 8.2% from 2024-2030. Radiofrequency identification (RFID) arrangements in medicinal services enhance quiet care, decreasing blunders, and giving effective stock administration. RFID arrangements in medicinal services include labeling tolerant documents, wristbands, supplies, and gear with labels that can be immediately checked. A speedy output of a tag can recover vital (and sometimes life-sparing) data about a patient, their solutions and treatment, or help find supplies required for treatment. The utilization of RFID answers for blood checking will additionally propel human services and enhance tolerant well-being altogether.
Advanced technologies in non-invasive and minimally invasive techniques of RFID Blood Monitoring Systems will drive the market growth of hemodynamic monitoring systems. The rising prevalence of hypertension, obesity, diabetes care devices which lead to cardiac diseases is also driving the market growth. According to WHO reports, in 2012, globally about 17.5 Mn deaths were recorded because of cardiovascular diseases. The growing geriatric population along with the rise in investments allocating to the geriatric will drive the growth of the RFID Blood Monitoring Systems systems market. The availability of reimbursement policies in industrialized economies will boost growth. However, the growing incidence of adverse reactions associated with, strict FDA regulations is hindering market growth.
Study Period
2024-2030Base Year
2023CAGR
8.2%Largest Market
Asia-PacificFastest Growing Market
North-America
Growing initiatives taken by the government in order to give awareness regarding respiratory and cardiovascular diseases will drive the market growth. For example, government of India developed NPDCS (National Programme for Prevention and Control of Diabetes, Cardiovascular diseases, and Stroke) with a moto of improving public health. Programs like European Heart Health Charter which was developed by European society of cardiology in association with European heart network in order to raise awareness on cardiac diseases. Initiatives, like European platform for health, physical activity and diet are undertaken by European government for the promotion of good health and to decrease the life style diseases.
North American holds he leading position in RFID Blood Monitoring Systems market. Especially US and Canada owing to drastic increasing in patient pool of cardiovascular and cancer diseases. As per American Heart Association, in 2015, over 69.0% of the population are suffering with cardiac arrest and around 77.0% of the population are suffering from strokes.
Asia pacific is also expected to witness significant growth due to increasing prevalence of cardiovascular disease, growing technological advancements, rapid growth in economy and favourable initiatives by the government initiatives. Latin America is expected to show considerable growth due to lifestyles changes and increasing prevalence of cardio vascular disease.
According to World heart federation, Latin America holds high risk of abdominal obesity, high blood cholesterol, hypertension etc. In 2015, According to the study, about 1.6Mn deaths are recording in Latin America and the Caribbean because of cardiovascular diseases. The universal healthcare scheme in Brazil along with rising government focus for ameliorating public health should fuel the market growth.Players are focussing on the major collobortaions, mergers and acquasitions in order to enhance their market share. For example, in 2016, LiDCO and Edwards Lifesciences Corporation entered into a strategic collaboration
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 114.2 million |
|
Market CAGR |
8.2% |
|
By Product Type |
|
|
By End User |
|
|
By Region |
|
Download Free Sample Report
The global rfid blood monitoring systems market size was valued at US$ 114.2 million in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030.
The rfid blood monitoring systems market key players are: Abbott Laboratories (U.S.) Biosense Webster, Inc. (U.S.) BIOTRONIK SE & Co. KG (Germany) Boston Scientific Corporation (U.S.) GE Healthcare (U.K.) Koninklijke Philips N.V. (The Netherlands) Medtronic, Inc. (U.S.) Microport Scientific Corporation (China) Jude Medical, Inc. (U.S.) Siemens AG (Germany).
The rfid blood monitoring systems market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
| 1. Executive Summary |
| 2. Global RFID Blood Monitoring Systems Market Introduction |
| 2.1.Global RFID Blood Monitoring Systems Market - Taxonomy |
| 2.2.Global RFID Blood Monitoring Systems Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.End Users |
| 2.2.3.Geography |
| 2.2.4.Region |
| 3. Global RFID Blood Monitoring Systems Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Global RFID Blood Monitoring Systems Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global RFID Blood Monitoring Systems Market By Product Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Systems |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Tags |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6. Global RFID Blood Monitoring Systems Market By End Users , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Blood Banks |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Hospital Blood Centers |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Hospitlals |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 7. Global RFID Blood Monitoring Systems Market By Geography, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Asia Pacific |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Europe |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Latin America |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8. Global RFID Blood Monitoring Systems Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9. North America RFID Blood Monitoring Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Systems |
| 9.1.2.Tags |
| 9.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Blood Banks |
| 9.2.2.Hospital Blood Centers |
| 9.2.3.Hospitlals |
| 9.3. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.North America |
| 9.3.2.Asia Pacific |
| 9.3.3.Europe |
| 9.3.4.Latin America |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10. Europe RFID Blood Monitoring Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Systems |
| 10.1.2.Tags |
| 10.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Blood Banks |
| 10.2.2.Hospital Blood Centers |
| 10.2.3.Hospitlals |
| 10.3. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.North America |
| 10.3.2.Asia Pacific |
| 10.3.3.Europe |
| 10.3.4.Latin America |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11. Asia Pacific (APAC) RFID Blood Monitoring Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Systems |
| 11.1.2.Tags |
| 11.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Blood Banks |
| 11.2.2.Hospital Blood Centers |
| 11.2.3.Hospitlals |
| 11.3. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.North America |
| 11.3.2.Asia Pacific |
| 11.3.3.Europe |
| 11.3.4.Latin America |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12. Middle East and Africa (MEA) RFID Blood Monitoring Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Systems |
| 12.1.2.Tags |
| 12.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Blood Banks |
| 12.2.2.Hospital Blood Centers |
| 12.2.3.Hospitlals |
| 12.3. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.North America |
| 12.3.2.Asia Pacific |
| 12.3.3.Europe |
| 12.3.4.Latin America |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13. Latin America RFID Blood Monitoring Systems Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Systems |
| 13.1.2.Tags |
| 13.2. End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Blood Banks |
| 13.2.2.Hospital Blood Centers |
| 13.2.3.Hospitlals |
| 13.3. Geography Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.North America |
| 13.3.2.Asia Pacific |
| 13.3.3.Europe |
| 13.3.4.Latin America |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Abbott Laboratories (U.S.) |
| 14.2.2.Biosense Webster, Inc. (U.S.) |
| 14.2.3.BIOTRONIK SE & Co. KG (Germany) |
| 14.2.4.Boston Scientific Corporation (U.S.) |
| 14.2.5.GE Healthcare (U.K.) |
| 14.2.6.Koninklijke Philips N.V. (The Netherlands) |
| 14.2.7.Medtronic, Inc. (U.S.) |
| 14.2.8.Microport Scientific Corporation (China) |
| 14.2.9.Jude Medical, Inc. (U.S.) |
| 14.2.10 Siemens AG (Germany). |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.